Versant Venture Capital VII, L.P.'s Net Worth
Estimate Recalculated Sep 9, 2024 12:31AM EST
Who is Versant Venture Capital VII, L.P.
Versant Venture Capital VII, L.P. has an estimated net worth of $16.7 Million. This is based on reported shares across multiple companies, which include CHINOOK THERAPEUTICS, INC., RayzeBio, Inc., and LENZ Therapeutics, Inc..
SEC CIK
Versant Venture Capital VII, L.P.'s CIK is 0001750266
Past Insider Trading and Trends
2022 was Versant Venture Capital VII, L.P.'s most active year for disposing of shares, totalling 2 transactions. Versant Venture Capital VII, L.P.'s most active month to dispose stocks was the month of December. In 2022 Versant Venture Capital VII, L.P. cashed out on 1,309,953 shares for a total of $9,600,120.00, their largest year based on trade value.
Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
